Literature DB >> 31159702

Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy.

Marco Pasi1, Thanakit Pongpitakmetha2,1, Andreas Charidimou1, Sanjula D Singh1, Hsin-Hsi Tsai3, Li Xiong1, Gregoire Boulouis4, Andrew D Warren1, Jonathan Rosand5, Matthew P Frosch6, Anand Viswanathan1, M Edip Gurol1, Steven M Greenberg1.   

Abstract

Background and Purpose- Hematoma location within the cerebellum may help identify the dominant small vessel disease type (cerebral amyloid angiopathy [CAA] versus nonamyloid small vessel disease). However, it is unknown whether this holds true for cerebral microbleeds (CMBs) within the cerebellum. We tested the hypothesis that cerebellar CMBs restricted to the cortex and vermis (defined as superficial regions) are associated with clinically diagnosed and pathology-verified CAA. Methods- Three hundred and seven consecutive spontaneous intracerebral hemorrhage (ICH) patients with a baseline magnetic resonance imaging that included susceptibility-weighted imaging or angiography were enrolled. Using a topographical template, cerebellar CMB patterns were defined as strictly superficial versus deep (cerebellar gray nuclei and white matter) or mixed (both regions involved). Thirty-six ICH patients with cerebellar CMBs and neuropathology data available were evaluated for the presence of CAA. Results- One hundred and thirty-five (44%) ICH patients had CMBs in the cerebellum. In the patient group with cerebellar CMBs, 85 (63%) showed a superficial pattern, and 50 (37%) had a deep/mixed pattern. Strictly superficial cerebellar CMBs were independently associated with a supratentorial pattern of probable CAA-ICH according to the Boston criteria (odds ratio, 1.6; CI, 1.03-2.5) and deep/mixed cerebellar CMBs with a pattern of deep/mixed ICH (odds ratio, 1.8; CI, 1.2-2.7). Pathologically verified CAA was present in 23 of 24 (96%) patients with superficial cerebellar CMBs versus 3 of 12 (25%) patients with deep/mixed cerebellar CMBs ( P<0.001). Conclusions- In ICH patients, cerebellar CMBs are relatively common and often restricted to superficial regions. A strictly superficial distribution of cerebellar CMBs is associated with clinically diagnosed and pathologically verified CAA.

Entities:  

Keywords:  cerebellum; cerebral amyloid angiopathy; cerebral hemorrhage

Mesh:

Year:  2019        PMID: 31159702      PMCID: PMC6599711          DOI: 10.1161/STROKEAHA.119.024843

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  25 in total

1.  Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds.

Authors:  Ah-Ling Cheng; Saima Batool; Cheryl R McCreary; M L Lauzon; Richard Frayne; Mayank Goyal; Eric E Smith
Journal:  Stroke       Date:  2013-08-06       Impact factor: 7.914

2.  Cerebellar Hematoma Location: Implications for the Underlying Microangiopathy.

Authors:  Marco Pasi; Sandro Marini; Andrea Morotti; Gregoire Boulouis; Li Xiong; Andreas Charidimou; Alison M Ayres; Myung Joo Lee; Alessandro Biffi; Joshua N Goldstein; Jonathan Rosand; M Edip Gurol; Steven M Greenberg; Anand Viswanathan
Journal:  Stroke       Date:  2017-11-28       Impact factor: 7.914

3.  Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy.

Authors:  S M Greenberg; J P Vonsattel
Journal:  Stroke       Date:  1997-07       Impact factor: 7.914

4.  The vascularization of the human cerebellar cortex.

Authors:  H Duvernoy; S Delon; J L Vannson
Journal:  Brain Res Bull       Date:  1983-10       Impact factor: 4.077

5.  Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease.

Authors:  Marco Pasi; Gregoire Boulouis; Panagiotis Fotiadis; Eitan Auriel; Andreas Charidimou; Kellen Haley; Alison Ayres; Kristin M Schwab; Joshua N Goldstein; Jonathan Rosand; Anand Viswanathan; Leonardo Pantoni; Steven M Greenberg; M Edip Gurol
Journal:  Neurology       Date:  2017-05-05       Impact factor: 9.910

6.  Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.

Authors:  M E Gurol; M C Irizarry; E E Smith; S Raju; R Diaz-Arrastia; T Bottiglieri; J Rosand; J H Growdon; S M Greenberg
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

7.  Cerebral amyloid angiopathy in the aged.

Authors:  M Yamada; H Tsukagoshi; E Otomo; M Hayakawa
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

8.  Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds.

Authors:  F Fazekas; R Kleinert; G Roob; G Kleinert; P Kapeller; R Schmidt; H P Hartung
Journal:  AJNR Am J Neuroradiol       Date:  1999-04       Impact factor: 3.825

Review 9.  Cerebral microbleeds: a guide to detection and interpretation.

Authors:  Steven M Greenberg; Meike W Vernooij; Charlotte Cordonnier; Anand Viswanathan; Rustam Al-Shahi Salman; Steven Warach; Lenore J Launer; Mark A Van Buchem; Monique Mb Breteler
Journal:  Lancet Neurol       Date:  2009-02       Impact factor: 44.182

10.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.

Authors:  Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

View more
  11 in total

1.  The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.

Authors:  Andreas Charidimou; Gregoire Boulouis; Matthew P Frosch; Jean-Claude Baron; Marco Pasi; Jean Francois Albucher; Gargi Banerjee; Carmen Barbato; Fabrice Bonneville; Sebastian Brandner; Lionel Calviere; François Caparros; Barbara Casolla; Charlotte Cordonnier; Marie-Bernadette Delisle; Vincent Deramecourt; Martin Dichgans; Elif Gokcal; Jochen Herms; Mar Hernandez-Guillamon; Hans Rolf Jäger; Zane Jaunmuktane; Jennifer Linn; Sergi Martinez-Ramirez; Elena Martínez-Sáez; Christian Mawrin; Joan Montaner; Solene Moulin; Jean-Marc Olivot; Fabrizio Piazza; Laurent Puy; Nicolas Raposo; Mark A Rodrigues; Sigrun Roeber; Jose Rafael Romero; Neshika Samarasekera; Julie A Schneider; Stefanie Schreiber; Frank Schreiber; Corentin Schwall; Colin Smith; Levente Szalardy; Pascale Varlet; Alain Viguier; Joanna M Wardlaw; Andrew Warren; Frank A Wollenweber; Marialuisa Zedde; Mark A van Buchem; M Edip Gurol; Anand Viswanathan; Rustam Al-Shahi Salman; Eric E Smith; David J Werring; Steven M Greenberg
Journal:  Lancet Neurol       Date:  2022-08       Impact factor: 59.935

2.  Cerebellar hemorrhages in patients with Dutch-type hereditary cerebral amyloid angiopathy.

Authors:  S Voigt; P C de Kruijff; E A Koemans; I Rasing; E S van Etten; G M Terwindt; Mjp van Osch; M A van Buchem; Maa van Walderveen; Mjh Wermer
Journal:  Int J Stroke       Date:  2021-09-10       Impact factor: 6.948

3.  Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.

Authors:  Stuart J McCarter; Timothy G Lesnick; Val J Lowe; Alejandro A Rabinstein; Scott A Przybelski; Alicia Algeciras-Schimnich; Vijay K Ramanan; Clifford R Jack; Ronald C Petersen; David S Knopman; Bradley F Boeve; Kejal Kantarci; Prashanthi Vemuri; Michelle M Mielke; Jonathan Graff-Radford
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

4.  Cerebral Microbleeds: Relationship to Antithrombotic Medications.

Authors:  Jonathan Graff-Radford; Timothy Lesnick; Alejandro A Rabinstein; Jeffrey L Gunter; Scott A Przybelski; Peter A Noseworthy; Gregory M Preboske; Michelle M Mielke; Val J Lowe; David S Knopman; Ronald C Petersen; Walter K Kremers; Clifford R Jack; Prashanthi Vemuri; Kejal Kantarci
Journal:  Stroke       Date:  2021-05-10       Impact factor: 10.170

Review 5.  A practical approach to the management of cerebral amyloid angiopathy.

Authors:  Mariel G Kozberg; Valentina Perosa; M Edip Gurol; Susanne J van Veluw
Journal:  Int J Stroke       Date:  2020-11-29       Impact factor: 6.948

6.  Prediction of amyloid β PET positivity using machine learning in patients with suspected cerebral amyloid angiopathy markers.

Authors:  Young Hee Jung; Hyejoo Lee; Hee Jin Kim; Duk L Na; Hyun Jeong Han; Hyemin Jang; Sang Won Seo
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

Review 7.  Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management.

Authors:  Maria Clara Zanon Zotin; Lukas Sveikata; Anand Viswanathan; Pinar Yilmaz
Journal:  Curr Opin Neurol       Date:  2021-04-01       Impact factor: 6.283

8.  Cerebellar and Cerebral Amyloid Visualized by [18F]flutemetamol PET in Long-Term Hereditary V30M (p.V50M) Transthyretin Amyloidosis Survivors.

Authors:  Erica Irene Uneus; Christer Wilhelmsson; David Bäckström; Intissar Anan; Jonas Wixner; Björn Pilebro; Katrine Riklund; Mattias Ögren; Margareta Ögreen; Jan Axelsson; Ole B Suhr; Torbjörn Sundström
Journal:  Front Neurol       Date:  2022-03-04       Impact factor: 4.003

9.  Clinical Prediction Model for Screening Acute Ischemic Stroke Patients With More Than 10 Cerebral Microbleeds.

Authors:  Yifan Li; Haifeng Gao; Dongsen Zhang; Xuan Gao; Lin Lu; Chunqin Liu; Qian Li; Chunzhi Miao; Hongying Ma; Yongqiu Li
Journal:  Front Neurol       Date:  2022-04-07       Impact factor: 4.003

10.  Identification of occult cerebral microbleeds in adults with immune thrombocytopenia.

Authors:  Nichola Cooper; Melanie A Morrison; Camelia Vladescu; Alice C J Hart; Deena Paul; Amna Malik; Thomas Young; Asad Luqmani; Maria Atta; David J Sharp; James B Bussel; Adam D Waldman
Journal:  Blood       Date:  2020-12-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.